Filing metadata

Accession number
0001062993-22-000244
Form type
Form 4
Filer
Avalo Therapeutics, Inc.
CIK
CIK 1534120
Filed
Jan 04, 2022
Reporting period
Dec 31, 2021
Description
Insider transaction

Explore SEC Filings Hub